Tesla(TSLA.US)上月歐洲銷量按年跌28% 連跌五個月
歐洲汽車製造商協會(ACEA)公布,5月歐洲整體汽車銷售上升1.9%,當中純電動車銷量上升27.2%,但Tesla(TSLA.US)銷量跌27.9%,連跌第五個月,令Tesla在歐洲的市佔率從一年前的1.8%降至1.2%。
5月歐盟、英國及歐洲自由貿易聯盟的新車銷量轉升至111萬輛,而4月則下降0.3%。當中,上汽集團(600104.SH)及寶馬的新車銷量分別上升22.5%及5.6%,而萬事得(7261.JP)則跌23%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.